Recent Advances in the Treatment of Chronic GVHD: ASH 2024 - Episode 9

Future Perspectives and Key Takeaways

Panelists discuss the role of combination therapies in the management of graft-vs-host disease (GVHD), exploring the potential benefits and challenges of using multiple agents concurrently to improve treatment outcomes and manage complications.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Understanding Graft-VS-Host Disease (GVHD) Basics
    EP. 2: Early Diagnosis and Intervention in GVHD Part 1
    EP. 3: Early Diagnosis and Intervention in GVHD Part 2
    EP. 4: Managing Skin Manifestations and Organ Involvement in GVHD
    EP. 5: Treatment Decision-Making in Chronic GVHD
    EP. 6: NCCN Guidelines and Clinical Updates in Chronic GVHD
    EP. 7: FDA-Approved Therapies for Chronic GVHD
    EP. 8: Challenges, Limitations, and Treatment Sequencing in Chronic GVHD
    Now Viewing
    EP. 9: Future Perspectives and Key Takeaways

    Video content above is prompted by the following:

    Can you discuss the role of combination therapies in the management of GVHD? What are the potential benefits and challenges of using multiple agents concurrently?

    x